Results 161 to 170 of about 1,334,045 (336)
Can Patient-Reported Outcome Measures Identify Cancer Patients' Most Bothersome Issues? [PDF]
, 2011 Claire Snyder +6 more
openalex +1 more source
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
What Is Sufficient Evidence for the Reliability and Validity of Patient-Reported Outcome Measures?
, 2007 Marlene H. Frost +4 more
openalex +1 more source
Patient-reported Outcome Measures in Multiple Sclerosis.
International MS journal, 2006 Patient-reported outcome (PRO) measures are being used more frequently in epidemiological studies, health service research and in clinical trials to evaluate therapeutic interventions from the patient's perspective. In MS, where evaluations of treatments are becoming increasingly important, outcome measures that are rigorous and appropriate to patients
openaire +8 more sources
Assessing patient reported outcome measures: A practical guide for gastroenterologists [PDF]
, 2014 Bombardier C +12 more
core +1 more source
Molecular Oncology, EarlyView.Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho +11 more
wiley +1 more source
PRM64 The Role of the Instrument Developer in the Translation of Patient Reported Outcome Measures [PDF]
, 2011 Darren Clayson +3 more
openalex +1 more source
The use of patient reported outcome measures (PROMs) in clinical assessment. [PDF]
, 2018 Black +20 more
core +1 more source
Patient-reported outcome measures and patient-reported experience measures [PDF]
BJA Education, 2017 Sanjiv Patel, Charlotte Kingsley
openaire +2 more sources
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski +19 more
wiley +1 more source